Welcome to MyCLL
This website is intended only for UK patients who have been prescribed Calquence▼ (acalabrutinib). This website has been produced and funded by AstraZeneca.
Please select the relevant option:
CLL, chronic lymphocytic leukaemia
GB-69344 | November 2025
This website is intended only for UK patients who have been prescribed Calquence▼ (acalabrutinib). This website has been produced and funded by AstraZeneca.
Please select the relevant option: